SCHEMBL6748574

SCHEMBL6748574

CC(=NO)c1cnccn1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
NAPRT Q6XQN6 1/20 0.48
HCAR2 Q8TDS4 1/20 0.48
BAZ2B Q9UIF8 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
TSHR P16473 1/20 0.47
MC4R P32245 1/20 0.47
ADRA1A P35348 1/20 0.47
MC3R P41968 1/20 0.47
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.43
HSP90AA1 P07900 3/20 0.43
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPT P10636 3/20 0.40
KMT2A Q03164 2/20 0.40
RXFP1 Q9HBX9 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14434128 1.00 KDM4E (0.53) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL9876452 0.81 BAZ2B (0.50) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL25154231 0.78 KDM4E (0.44) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL27923673 0.77
SCHEMBL29775332 0.76 KDM4E (0.56) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL640864 0.74 BAZ2B (0.57) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL640865 0.74 BAZ2B (0.57) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL4399126 0.74 KDM4E (0.48) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL4399128 0.74 KDM4E (0.48) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL14903392 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117866247-A Preparation method of polyimide film with high glass transition temperature and high light transmittance 苏州亿曼煜科技有限公司 2024-04-12 CN disclosed
US-6777412-B2 PYRIMIDIN-4-YLOXY)PHENYL)-3-METHOXYPROPENOATE DERIVATIVES SYNGENTA LIMITED (GB) 2004-08-17 US disclosed
US-20040092746-A1 Pyrimidinyloxyphenyl-3-alkoxypropenoate derivatives as pesticides CLOUGH JOHN MARTIN (GB) 2004-05-13 US disclosed
US-6613773-B2 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives SYNGENTA LIMITED (GB) 2003-09-02 US disclosed
US-20030060626-A1 Fungicides SYNGENTA LIMITED (GB) 2003-03-27 US disclosed
CN-1060289-A Mycocide ICI PLC (GB) 1992-04-15 CN disclosed
EP-0468695-A1 Fungicides ZENECA LIMITED (GB) 1992-01-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092746-A1 Pyrimidinyloxyphenyl-3-alkoxypropenoate derivatives as pesticides DDT, SQOR, TH KDM4E 418/4885NAPRT 2462/4885HCAR2 3570/4885
US-20030060626-A1 Fungicides CYP51A1, CYP1A1, CYP1A2 KDM4E 335/4885NAPRT 3119/4885HCAR2 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.